1. Home
  2. ARDX vs SHAZ Comparison

ARDX vs SHAZ Comparison

Compare ARDX & SHAZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ardelyx Inc.

ARDX

Ardelyx Inc.

HOLD

Current Price

$5.09

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Logo SharonAI Holdings Inc. Class A Common Stock

SHAZ

SharonAI Holdings Inc. Class A Common Stock

N/A

Current Price

$45.38

Market Cap

1.6B

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
ARDX
SHAZ
Founded
2007
2024
Country
United States
United States
Employees
N/A
30
Industry
Biotechnology: Pharmaceutical Preparations
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.6B
IPO Year
2014
N/A

Fundamental Metrics

Financial Performance
Metric
ARDX
SHAZ
Price
$5.09
$45.38
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
3
Target Price
$15.14
$46.67
AVG Volume (30 Days)
3.4M
1.9M
Earning Date
04-30-2026
06-23-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,607,000.00
N/A
Revenue This Year
$37.75
$8,711.27
Revenue Next Year
$34.24
$587.87
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.08
$16.55
52 Week High
$8.40
$97.48

Technical Indicators

Market Signals
Indicator
ARDX
SHAZ
Relative Strength Index (RSI) 38.69 31.85
Support Level $4.95 $18.86
Resistance Level $5.34 $85.76
Average True Range (ATR) 0.17 7.66
MACD 0.01 -2.48
Stochastic Oscillator 21.12 0.35

Price Performance

Historical Comparison
ARDX
SHAZ

About ARDX Ardelyx Inc.

Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. Its products Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.

About SHAZ SharonAI Holdings Inc. Class A Common Stock

SharonAI Holdings Inc is a neocloud operator, purpose-built to power the next generation of artificial intelligence (AI) and high-performance computing (HPC). The Company's infrastructure is architected from the ground up to meet the specific, intensive, and complex demands of modern AI training and inference workloads, machine learning, and Generative AI. Its services include: Sovereign AI Australia, GPU-as-a-Service, SHARON AI Cloud, SHARON AI Private Cloud, Virtual Private Clusters, HPC Servers, and SHARON AI Studio. The company's products are: SHARON AI Supercluster, GPU Fleet, Virtual Servers, Cloud Storage, and Machine Learning & Infrastructure. The Company operates in one operating segment, High Performance Compute Services (HPC).

Share on Social Networks: